The information in this section is intended for visitors outside the United States.
Foster City, CA, August 1, 2016 – Gilead Sciences, Inc. today announced that it issued its first Corporate Social Responsibility Report, which provides an overview of the work the company is doing around the world to improve the lives of people with life-threatening diseases and to make a positive impact on public health and local communities.
“A genuine sense of corporate citizenship has long been at the heart of everything we do,” said John Milligan, PhD, President and Chief Executive Officer, Gilead Sciences. “As CEO, my vision for Gilead is to continue to innovate at every level – delivering lifesaving medicines to patients and making a positive contribution to all of the communities we serve and of which we are a part.”
The report focuses on four key areas of Giving and Access, People, Products and Environment. 2015 highlights from each of these include:
To find out more about Gilead’s 2015 Corporate Social Responsibility Report, visit: www.gilead.com/csr2015
About Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. We strive to transform and simplify care for people with life-threatening illnesses around the world, always keeping the patients and the communities we serve at the forefront.